The global implantable drug delivery devices hold a competitive edge over other drugs and devices owing to the fact that they are implanted at targeted sites and so deliver unaltered amounts of drugs to the affected area. These implantable drug delivery devices are categorized into six product types and this report estimates their market in terms of USD million, for the period 2012 – 2018, keeping 2011 as the base year.

TechNavios analysts forecast the Global Nanotechnology Drug Delivery market to
grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key
factors contributing to this market growth is the low R&D cost. The Global
Nanotechnology Drug Delivery market has also been witnessing an increase in
customer support services. However, the increasing safety concerns could pose a
challenge to the growth of this market.
Global Nanotechnology Drug Delivery Market 2012-2016, has been prepared based on

US demand for drug delivery products is forecast to expand 7.2 percent annually to $133 billion in 2015. The best growth opportunities will emerge in specialized pharmaceutical formulations and administration devices that advance the nature of therapy for autoimmune conditions, cancer, heart disease, neurological disorders and other debilitating health problems. Included in this group are human monoclonal antibodies, polymer encapsulated nanomedicines and transdermal patches for breakthrough pain management.